Functional signaling test identifies HER2 negative breast cancer patients who may benefit from c-Met and pan-HER combination therapy

Functional test reveals patients who may benefit from c-Met+pan-HER breast cancer therapy

User Research Square on YouTube, 12 Jan 2022

MacNeil, et al. “Functional signaling test identifies HER2 negative breast cancer patients who may benefit from c-Met and pan-HER…